Climb Bio, Inc. SEC filings CLYM
Climb Bio, Inc. has 325 filings in SEC EDGAR's recent list, going back to Feb 19, 2019. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Nov 5, 2026 | — |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 26, 2026 | Oct 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Other events
|
Aug 14, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 12, 2026 | Jun 11, 2026 |
| 424B5 | Prospectus supplement | Jun 12, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 11, 2026 | Jun 11, 2026 |
| EFFECT | Filing | Jun 9, 2026 | — |
| 424B3 | Prospectus | Jun 9, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 8, 2026 | Jun 5, 2026 |
| CORRESP | Letter to the SEC | Jun 5, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 5, 2026 | Jun 5, 2026 |
| UPLOAD | Letter from the SEC | Jun 4, 2026 | — |
| S-3 | Shelf registration | May 29, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 5, 2026 | May 5, 2026 |
| D | Filing | May 4, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 28, 2026 | Apr 27, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 5, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2026 | Apr 1, 2026 |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Other events
|
Dec 31, 2025 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 11, 2025 | Dec 11, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 17, 2025 | Oct 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 29, 2025 | Sep 29, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 4, 2025 |
| DEFA14A | Additional proxy material | May 23, 2025 | — |
| 8-K |
Current report
Officer or director change
|
May 23, 2025 | May 23, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 4, 2025 |
| S-8 | Employee stock plan registration | Apr 1, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Material agreement, Results of operations
|
Mar 25, 2025 | Mar 25, 2025 |
| 424B5 | Prospectus supplement | Mar 25, 2025 | — |
| 10-K | Annual report | Mar 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jan 10, 2025 | Jan 8, 2025 |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2024 | — |
| S-3 | Shelf registration | Nov 12, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 2, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2024 | Aug 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 26, 2024 | Aug 26, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| EFFECT | Filing | Jul 23, 2024 | — |
| 424B3 | Prospectus | Jul 23, 2024 | — |
| CORRESP | Letter to the SEC | Jul 19, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2024 | — |
| S-3 | Shelf registration | Jul 12, 2024 | — |
| D | Filing | Jul 2, 2024 | — |
| D | Filing | Jul 2, 2024 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| DEFA14A | Additional proxy material | Jun 14, 2024 | — |
| DEFA14A | Additional proxy material | Jun 12, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 12, 2024 | Jun 12, 2024 |
| ARS | Annual report to shareholders | Jun 4, 2024 | Dec 31, 2023 |
| DEFM14A | Filing | Jun 4, 2024 | — |
| PREM14A | Filing | May 17, 2024 | May 17, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Apr 11, 2024 | Apr 10, 2024 |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Mar 19, 2024 | Mar 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 20, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2023 | May 18, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 6, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 6, 2023 | — |
| DEF 14A | Proxy statement | Apr 6, 2023 | May 18, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 16, 2023 | Mar 10, 2023 |
| S-8 | Employee stock plan registration | Mar 6, 2023 | — |
| 8-K |
Current report
Results of operations
|
Mar 6, 2023 | Mar 6, 2023 |
| 10-K | Annual report | Mar 6, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Other events
|
Feb 14, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 24, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 5, 2022 | Oct 5, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Other events
|
Jul 18, 2022 | Jul 18, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2022 | May 19, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Other events
|
Apr 25, 2022 | Apr 25, 2022 |
| DEFA14A | Additional proxy material | Apr 8, 2022 | — |
| DEF 14A | Proxy statement | Apr 8, 2022 | May 19, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 29, 2022 | Mar 28, 2022 |
| S-8 | Employee stock plan registration | Mar 7, 2022 | — |
| 8-K |
Current report
Results of operations
|
Mar 7, 2022 | Mar 7, 2022 |
| 10-K | Annual report | Mar 7, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2022 | Jan 27, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 18, 2022 | Jan 18, 2022 |
| 8-K |
Current report
Other events
|
Nov 22, 2021 | Nov 22, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2021 | Nov 8, 2021 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K/A |
Amended current report
Results of operations
|
Sep 14, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 13, 2021 | Sep 13, 2021 |
| 10-Q | Quarterly report | Sep 13, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 12, 2021 | Aug 12, 2021 |
| S-8 | Employee stock plan registration | Aug 12, 2021 | — |
| 424B4 | Prospectus | Aug 11, 2021 | — |
| EFFECT | Filing | Aug 9, 2021 | — |
| S-1MEF | Filing | Aug 9, 2021 | — |
| S-1/A | Amended registration statement | Aug 9, 2021 | — |
| CORRESP | Letter to the SEC | Aug 9, 2021 | — |
| CORRESP | Letter to the SEC | Aug 9, 2021 | — |
| FWP | Free writing prospectus | Aug 9, 2021 | — |
| S-1/A | Amended registration statement | Aug 9, 2021 | — |
| CERT | Filing | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Aug 4, 2021 | — |
| CORRESP | Letter to the SEC | Aug 4, 2021 | — |
| CORRESP | Letter to the SEC | Aug 3, 2021 | — |
| 8-A12B | Filing | Aug 3, 2021 | — |
| S-1/A | Amended registration statement | Aug 3, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 2, 2021 | — |
| S-1/A | Amended registration statement | Aug 2, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| S-1 | Registration statement | Jul 16, 2021 | — |
| DRSLTR | Filing | Jul 12, 2021 | — |
| DRS/A | Filing | Jul 12, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2021 | — |
| DRSLTR | Filing | Jun 21, 2021 | — |
| DRS/A | Filing | Jun 21, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2021 | — |
| D | Filing | May 28, 2021 | — |
| DRS | Filing | May 12, 2021 | — |
| D | Filing | Nov 3, 2020 | — |
| D | Filing | Oct 23, 2019 | — |
| D/A | Filing | Oct 23, 2019 | — |
| D | Filing | Feb 19, 2019 | — |
Showing 165 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLYM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wellesley Hills, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1768446
- Former names
- Eliem Therapeutics, Inc. (until Sep 20, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.